Mayne Pharma Group (Mayne Pharma Group) EV-to-Revenue : 1.01 (As of Jun. 24, 2024)

View and export this data going back to 2013. Start your Free Trial

What is Mayne Pharma Group EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Mayne Pharma Group's enterprise value is $182.5 Mil. Mayne Pharma Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $180.2 Mil. Therefore, Mayne Pharma Group's EV-to-Revenue for today is 1.01.

The historical rank and industry rank for Mayne Pharma Group's EV-to-Revenue or its related term are showing as below:

MAYNF' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.42 Med: 2.29 Max: 7.94
Current: 1.02

During the past 13 years, the highest EV-to-Revenue of Mayne Pharma Group was 7.94. The lowest was 0.42. And the median was 2.29.

MAYNF's EV-to-Revenue is ranked better than
77.8% of 1018 companies
in the Drug Manufacturers industry
Industry Median: 2.23 vs MAYNF: 1.02

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-24), Mayne Pharma Group's stock price is $3.111. Mayne Pharma Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $2.21. Therefore, Mayne Pharma Group's PS Ratio for today is 1.41.

Mayne Pharma Group EV-to-Revenue Historical Data

The historical data trend for Mayne Pharma Group's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mayne Pharma Group EV-to-Revenue Chart

Mayne Pharma Group Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

EV-to-Revenue

Get a 7-Day Free Trial

2.09

2.00

2.04

1.77

1.07

Mayne Pharma Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															-	1.77	-	1.07	-

Competitive Comparison of Mayne Pharma Group's EV-to-Revenue

For the Drug Manufacturers - General subindustry, Mayne Pharma Group's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mayne Pharma Group's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mayne Pharma Group's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Mayne Pharma Group's EV-to-Revenue falls into.

Mayne Pharma Group EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Mayne Pharma Group's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	182.466	/	180.164
	=	1.01

Mayne Pharma Group's current Enterprise Value is $182.5 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Mayne Pharma Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $180.2 Mil.

Mayne Pharma Group (OTCPK:MAYNF) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Mayne Pharma Group's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	3.111	/	2.213
	=	1.41

Mayne Pharma Group's share price for today is $3.111.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was $2.21.

Mayne Pharma Group EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Mayne Pharma Group's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Mayne Pharma Group (Mayne Pharma Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mayne Pharma Group Ltd (OTCPK:MAYNF) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

HG6:Germany MYX:Australia

Address

1538 Main North Road, Salisbury South, Salisbury, SA, AUS, 5106

Website

http://www.maynepharma.com

Mayne Pharma Group Ltd is a specialty pharmaceutical company focused on commercializing novel and generic pharmaceuticals It has a Forty-year track record of innovation and success in developing oral drug delivery systems. The Company's Business consists of three operating segments being International, Branded Products (BPD) and Portfolio Products Division (PPD). The Portfolio Products Division distributes dermatology products (branded and generic) in the US on a portfolio basis, The Branded Products Division distributes branded women's health products in the US. International's segment revenue and gross profit are derived principally from the Australian manufacture and sale of branded and generic pharmaceutical products.